Product Code: PHA1215
The Gene Amplification Technologies market is projected to grow at a CAGR of 9.8% by 2033.
“The Gene Amplification Technologies Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand
Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as a growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume. A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).
The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers
The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).
What Questions Should You Ask before Buying a Market Research Report?
- How is the gene amplification technologies market evolving?
- What is driving and restraining the gene amplification technologies market?
- How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the gene amplification technologies projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
- Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:
- Our 425- page report provides 176 tables and 190 charts/graphs exclusively to you
- The report highlights key lucrative areas in the industry so you can target them - NOW
- It contains in-depth analysis of global, regional and national sales and growth
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
- You will find original analyses, with business outlooks and developments
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Market Segment by Sample Type
- Single Cell
- Formalin-Fixed & Paraffin-Embedded (FFPE)
Market Segment by End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End-Users
Market Segment by Business Type
- Gene Amplification Kits & Reagents
- Gene Amplification Instruments
- Gene Amplification Services
- Gene Amplification Ancillaries
Market Segment by Application
- Hybridization Application
- Whole Genome Amplification
- Exome Sequencing Amplification
- SNP Genotyping Arrays
- Array CGH
Market Segment by Technology
- PCR-based Amplification
- Loop-mediated Isothermal Amplification
- Nucleic Acid Sequence Based Amplification
- Strand Displacement Amplification
- Multiple Displacement Amplification
- Other Technology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
Europe
- Germany
- Spain
- United Kingdom
- France
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth:
- 4BASEBIO AG
- Abbott Laboratories
- Agilent Technologies, Inc
- Ambion Inc
- Bayer Pharmaceutics AG
- Becton Dickinson and Co
- Bio-Rad Laboratories
- Danaher Corporation
- Illumina Inc
- LGC Group
|
- Merck KGaA
- MyBioSource
- Nanjing Vazyme Biotech Co
- New England Biolabs
- PerkinElmer Inc
- Promega Corporation
- Qiagen N.V
- Silicon Biosystems
- Takara Bio Inc
- Yikang Inc.
|
Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Gene Amplification Technologies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1. Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Gene Amplification Technologies Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Research Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
2 Executive Summary
3 Premium Insights
- 3.1 Geographical Snapshot: Global Gene Amplification Technologies Market
- 3.2 Technology Segment: Market Attractiveness Index
- 3.3 Sample Type Segment: Market Attractiveness Index
- 3.4 End-User Segment: Market Attractiveness Index
- 3.5 Business Type Segment: Market Attractiveness Index
- 3.6 Application Segment: Market Attractiveness Index
4 Market Overview
- 4.1 Key Findings
- 4.2 Market Dynamics
- 4.2.1 Market Driving Factors
- 4.2.2 Market Restraining Factors
- 4.2.3 Market Opportunities
- 4.3 Supply Chain Overview
- 4.4 Value Chain Overview
- 4.5 Recent Trends and Developments
- 4.6 COVID-19 Impact Analysis
- 4.7 Porter's Five Forces Analysis
- 4.7.1 Supplier Power
- 4.7.2 Buyer Power
- 4.7.3 Competitive Rivalry
- 4.7.4 Threat from Substitutes
- 4.7.5 Threat of New Entrants
- 4.8 PESTLE Analysis
- 4.8.1 Political Factors
- 4.8.2 Economic Factors
- 4.8.3 Social Factors
- 4.8.4 Technological Factors
- 4.8.5 Legal Factors
- 4.8.6 Environmental Factors
5 Global Gene Amplification Technologies Market Analysis by Application
- 5.1 Key Findings
- 5.2 Global Market Outlook
- 5.3 Region Segment Growth Prospects
- 5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033
- 5.5 Global Gene Amplification Technologies Market Share Forecast
- 5.5.1 Pre-COVID-19 Market Scenario
- 5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
- 5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast
- 5.6.1 Pre-COVID-19 Market Scenario
- 5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Gene Amplification Technologies Market Analysis by Technology
- 6.1 Key Findings
- 6.2 Global Technology Market Outlook
- 6.3 Global Gene Amplification by Technology Market Attractiveness Index
- 6.4 Regional Market Size Estimation and Forecast
- 6.5 Amplification based on PCR
- 6.5.2 Global PCR-based Amplification Market Forecast
- 6.5.3 Global Cleavable Linkers Market Forecast by Region
- 6.6 Loop-mediated Isothermal Amplification
- 6.7 Global Loop-mediated Isothermal Amplification Market Forecast
- 6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region
- 6.8 Nucleic Acid Sequence Based Amplification
- 6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast
- 6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region
- 6.9 Strand Displacement Amplification
- 6.8.3 Strand Displacement Amplification Market Forecast
- 6.8.4 Global Strand Displacement Amplification Market Forecast by Region
- 6.10 Multiple Displacement Amplification
- 6.10.1 Multiple Displacement Amplification Market Forecast
- 6.8.5 Global Multiple Displacement Amplification Market Forecast by Region
- 6.11 Other Technology Amplification
- 6.8.6 Other Technology Amplification Market Forecast
7 Global Gene Amplification Technologies Market Analysis by Sample Type
- 7.1 Key Findings
- 7.2 Global Sample Type Market Outlook
- 7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index
- 7.3 Global Gene Amplification Technologies Market by Sample Type
- 7.4 Single Cell
- 7.4.1 Global Single Cell Market Forecast
- 7.4.2 Global Single Cell Market Forecast by Region
- 7.5 Formalin-Fixed, Paraffin-Embedded (FFPE)
- 7.5.1 Global FFPE Market Forecast
- 7.5.2 Global FFPE Market Forecast by Region
8 Global Gene Amplification Technologies Market Analysis by End-User
- 8.1 Key Findings
- 8.2 Global End-User Market Outlook
- 8.2.1 Global Gene Amplification by End-User Market Attractiveness Index
- 8.3 Global Gene Amplification Technologies Market by End-User Antigen
- 8.4 Pharmaceutical & Biotechnological Companies
- 8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast
- 8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region
- 8.5 Academic & Research Institute
- 8.5.1 Global Academic & Research Institute Market Forecast
- 8.5.2 Global Academic & Research Institute Market Forecast by End-User
9 Global Gene Amplification Technologies Market Analysis by Business Type
- 9.1 Key Findings
- 9.2 Global Business Type Market Outlook
- 9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index
- 9.3 Global Gene Amplification Technologies Market by Business Type
- 9.4 Kits & Reagents
- 9.4.1 Global Kits & Reagents Market Forecast
- 9.4.2 Global Kits & Reagents Market by Region
- 9.5 Instruments
- 9.5.1 Global Instruments Market Forecast
- 9.5.2 Global Instruments Market by Region
- 9.6 Services
- 9.6.1 Global Services Market Forecast
- 9.6.2 Global Services Market by Region
- 9.7 Ancillaries
- 9.7.1 Global Ancillaries Market Forecast
- 9.7.2 Global Ancillaries Market by Region
10 North America Market Analysis
- 10.1 Key Findings
- 10.2 Overview
- 10.2.2 North America Gene Amplification Technologies Market Attractiveness Index
- 10.3 North America Gene Amplification Technologies Market Size and Forecast by Value
- 10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country
- 10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
- 10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
- 10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
- 10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application
- 10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
- 10.10 US Market
- 10.10.1 The US Government's Foreign Investment Risk
- 10.10.2 The American Pharmaceutical Research and Manufacturers
- 10.11 Canada Market
- 10.11.1 Control of Laboratory-Developed Tests
- 10.11.2 Drug-related Expenses
11 Europe Market Analysis
- 11.1 Key Findings
- 11.2 Overview
- 11.3 Europe Gene Amplification Technologies Market Attractiveness Index
- 11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country
- 11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value
- 11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
- 11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User
- 11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
- 11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application
- 11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology
- 11.2 Germany Market
- 11.2.1 Germany Has a Robust and Broad Market
- 11.2.2 Inventive IVD industry
- 11.3 UK Market
- 11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs)
- 11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis
- 11.4 France Market
- 11.4.1 Molecular Diagnostics Market Expansion in France
- 11.4.2 Foreign Organisations Investing in France
- 11.5 Italy Market
- 11.5.1 Italian Pharmaceuticals' Advantage
- 11.5.2 Nucleic Acid Amplification Technology's (NAT) Effects in Italy
- 11.6 Spain Market
- 11.6.1 Spanish Clinical Genetics and Genomics
- 11.6.2 Expansion of Spain's pharmaceutical and R&D Industries
- 11.15 Rest of Europe Market Analysis
12 Asia-Pacific Market Analysis
- 12.1 Key Findings
- 12.2 Overview
- 12.2.1 The Commercial Effect of Polymerase Chain Reactions
- 12.2.2 Asia-Pacific Market for Gene Therapy
- 12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
- 12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value
- 12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country
- 12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
- 12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User
- 12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
- 12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application
- 12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology
- 12.3 China Market
- 12.3.1 China's Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations
- 12.3.2 Market Segment Analysis for Molecular Diagnostics
- 12.4 India Market
- 12.4.1 Advancements in POC Diagnostic Technology
- 12.4.2 India's Genome Engineering Technology Regulations
- 12.5 Japan Market
- 12.5.1 Japan's Ability to Use Genomic Medicine
- 12.5.2 Developments in Japanese Genetic Testing Regulation
- 12.14 South Korea Market
- 12.5.3 Pharmaceutical Industry Development in South Korea
- 12.6 Australia Market
- 12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection
- 12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach
- 12.7 Rest of Asia-Pacific Market Analysis
13 Middle East & Africa Market Analysis
- 13.1 Key Findings
- 13.2 Overview
- 13.2.1 MENA's Expanding Pharmaceutical Industry
- 13.2.2 MENA's Regulatory Environment
- 13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
- 13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value
- 13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country
- 13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
- 13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User
- 13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
- 13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application
- 13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology
- 13.3 South Africa Market Analysis
- 13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market
- 13.4 Saudi Arabia Market Analysis
- 13.4.1 Pharmacy Research and Development of Saudi Arabia
- 13.4.2 Rules and Regulations
- 13.5 Turkey Market Analysis
- 13.5.1 Turkish Regulatory Authority
- 13.5.2 Updates to the Recommendations for PCR Testing
- 13.6 Rest of Middle East and Africa Market Analysis
14 Latin America Market Analysis
- 14.1 Key Findings
- 14.2 Overview
- 14.2.1 Significantly Raise in Latin American Pharmaceutical Industry
- 14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts
- 14.3 Latin America Gene Amplification Technologies Market Attractiveness Index
- 14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value
- 14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country
- 14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
- 14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
- 14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
- 14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application
- 14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
- 14.11 Brazil Market
- 14.2.3 Brazil's Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis
- 14.2.4 Brazilian Government Regulations and Policies
- 14.3 Mexico Market
- 14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances
- 14.13 Rest of Latin America Market Analysis
15 Competitive Landscape
- 15.2 Key Business Strategy Analysis- Acquisition
- 15.3 Key Business Strategy Analysis- Agreement
- 15.4 Key Business Strategy Analysis- Collaboration
- 15.5 Key Business Strategy Analysis- Expansion
- 15.6 Key Business Strategy Analysis- Investment
- 15.7 Key Business Strategy Analysis- New Product Launch
- 15.8 Key Business Strategy Analysis- Partnership
- 15.9 Key Business Strategy Analysis- Development
- 15.10 Key Business Strategy Analysis- Joint Venture
16 Company Profiles
- 16.1 Merck KGaA
- 16.1.2 Company Snapshot
- 16.1.3 Company Overview
- 16.1.4 Financial Analysis
- 16.1.5 Product Benchmarking
- 16.1.6 Strategic Outlook
- 16.2 4BASEBIO AG
- 16.2.1 Company Snapshot
- 16.2.2 Company Overview
- 16.2.3 Financial Analysis
- 16.2.4 Product Benchmarking
- 16.2.5 Strategic Outlook
- 16.3 Abbott Laboratories (U.S.)
- 16.3.1 Company Snapshot
- 16.3.2 Company Overview
- 16.3.3 Financial Analysis
- 16.3.4 Product Benchmarking
- 16.3.5 Strategic Outlook
- 16.4 Agilent Technologies, Inc. (U.S.)
- 16.4.1 Company Snapshot
- 16.4.2 Company Overview
- 16.4.3 Financial Analysis
- 16.4.4 Product Benchmarking
- 16.4.5 Strategic Outlook
- 16.5 Ambion Inc.
- 16.5.1 Company Snapshot
- 16.5.2 Company Overview
- 16.5.3 Product Benchmarking
- 16.5.4 Strategic Outlook
- 16.6 Bayer Pharmaceutics
- 16.6.1 Company Snapshot
- 16.6.2 Company Overview
- 16.6.3 Financial Analysis
- 16.6.4 Product Benchmarking
- 16.6.5 Strategic Outlook
- 16.7 Becton Dickinson and Co.
- 16.7.1 Company Snapshot
- 16.7.2 Company Overview
- 16.8.4 Product Benchmarking
- 16.7.3 Financial Analysis
- 16.7.4 Product Benchmarking
- 16.7.5 Strategic Outlook
- 16.8 Bio-Rad Laboratories
- 16.8.1 Company Snapshot
- 16.8.2 Company Overview
- 16.8.3 Financial Analysis
- 16.8.5 Strategic Outlook
- 16.9 MyBioSource
- 16.9.1 Company Snapshot
- 16.9.2 Company Overview
- 16.9.3 Product Benchmarking
- 16.9.4 Strategic Outlook
- 16.10 Danaher Corporation
- 16.10.1 Company Snapshot
- 16.10.2 Company Overview
- 16.10.3 Financial Analysis
- 16.10.4 Product Benchmarking
- 16.10.5 Strategic Outlook
- 16.11 Illumina Inc.
- 16.11.1 Company Snapshot
- 16.11.2 Company Overview
- 16.11.3 Financial Analysis
- 16.11.4 Product Benchmarking
- 16.11.5 Strategic Outlook
- 16.12 LGC Group
- 16.12.1 Company Snapshot
- 16.12.2 Company Overview
- 16.12.3 Product Benchmarking
- 16.12.4 Strategic Outlook
- 16.13 Nanjing Vazyme Biotech Co.
- 16.13.1 Company Snapshot
- 16.13.3 Financial Analysis
- 16.13.4 Product Benchmarking
- 16.13.5 Strategic Outlook
- 16.14 New England Biolabs
- 16.14.1 Company Snapshot
- 16.14.2 Company Overview
- 16.14.3 Product Benchmarking
- 16.14.4 Strategic Outlook
- 16.15 PerkinElmer Inc.
- 16.15.1 Company Snapshot
- 16.15.3 Financial Analysis
- 16.15.4 Product Benchmarking
- 16.15.5 Strategic Outlook
- 16.16 Promega Corporation
- 16.16.1 Company Snapshot
- 16.16.2 Company Overview
- 16.16.3 Product Benchmarking
- 16.16.4 Strategic Outlook
- 16.17 Qiagen N.V.
- 16.17.1 Company Snapshot
- 16.17.3 Financial Analysis
- 16.17.4 Product Benchmarking
- 16.17.5 Strategic Outlook
- 16.18 Silicon Biosystems
- 16.18.1 Company Snapshot
- 16.18.2 Company Overview
- 16.18.3 Product Benchmarking
- 16.18.4 Strategic Outlook
- 16.19 Takara Bio Inc.
- 16.19.1 Company Snapshot
- 16.19.2 Company Overview
- 16.19.3 Financial Analysis
- 16.19.4 Product Benchmarking
- 16.19.5 Strategic Outlook
- 16.20 Yikang Inc.
- 16.20.1 Company Snapshot
- 16.20.2 Company Overview
- 16.20.3 Product Benchmarking
- 16.20.4 Strategic Outlook
17 Conclusion and Recommendations
- 17.1 Concluding Remarks from
- 17.2 Recommendations for Market Players